← All organizations
Highest phase reached
Phase 1
First clinical trial
Jan 1, 2018Last known activity
Jan 1, 2018
Timeline
2010s
- Jun 1, 2010
PersImmune, Inc— Founded
Drugs by trial phase (1 distinct, 1 trials)
Phase 1 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (2)
- NCT03258359Study directorPhase 1Jan 1, 2018
- NCT03258359Lead sponsorPhase 1Jan 1, 2018
Details
- Founded
- San Diego, CA, US Jun 1, 2010
- Last known activity
- Jan 1, 2018